Alcon AG | ALC - Equity Capital And Reserves


Alcon AG reported $22.13B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AstraZeneca USD 47.33B 1.33B Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Essilor EUR 38.89B 1.07B Dec/2025
Fresenius EUR 19.77B 1.14B Dec/2025
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
GRIFOLS EUR 5.46B 171M Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Philips EUR 11.39B 403M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
Smith & Nephew USD 5.54B 331M Dec/2025
Sonova Holding CHF 2.66B 374.5M Jun/2025
UCB EUR 10.87B 1.18B Dec/2025